Why did IVF stock spike pre-market today?

IVF stock spiked on heavy volume and momentum trading rather than a clear company announcement. Market chatter, recent clinic acquisitions and a thin float after reverse splits amplified the move.

What are the top financial risks for IVF stock?

Top risks include negative EPS (**-294.88**), low liquidity (current ratio **0.12**), repeated reverse splits, and reliance on successful clinic acquisitions to reach cash-flow breakeven.

How does Meyka AI view IVF stock in the near term?

Meyka AI assigns IVF a **62.69** score (Grade B, HOLD). The model flags high short-term volatility and projects a monthly target of **$1.03 USD**, noting forecasts are model-based and not guarantees.

Should I trade or hold IVF stock after today’s jump?

Today’s action suits short-term traders due to liquidity and momentum. Long-term holders should wait for sustained revenue growth or profitability before increasing allocation to IVF stock.

US Stocks

IVF (INVO Fertility, NASDAQ) up 191.73% pre-market Jan 21 2026: Most active with heavy volume

ByHuzaifa Zahoor January 21, 2026January 21, 2026

IVF stock is the most active pre-market mover on Jan 21 2026, trading at $2.37 USD after a 191.73% jump on unusually heavy volume of 259,560,376 shares. The move follows no formal company announcement, though investors continue to digest the company’s clinic acquisition strategy and recent 1-for-8 reverse split implemented in November 2025. INVO Fertility, Inc. (IVF) is listed on NASDAQ in the United States and reported FY 2024 clinic revenue of $7.70 million. Meyka AI’s platform flags the spike as high-risk momentum; we assess fundamentals, technicals, and model forecasts below to show what traders are watching